Researchers at UBC Okanagan have made two major discoveries that are set to revolutionize how scientists observe and measure molecular forces within living cells. Published recently in two ...
Transitioning molecular imaging from a preclinical technique to a standard clinical tool could help detect the very earliest stages of disease, reports Tami Freeman Tools of the trade Left: this ...
Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...
Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...
BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on ...
Reston, VA (August 20, 2024) -- A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, ...
Opportunities in the Middle East imaging biomarkers market include the expansion of advanced imaging infrastructure and increased adoption of biomarker-driven clinical pathways. Driven by rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results